{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:27:43Z","timestamp":1754108863177,"version":"3.37.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 MH095621","1R01 MH095621","R01 MH107345","R01 MH107345"],"award-info":[{"award-number":["1R01 MH095621","1R01 MH095621","R01 MH107345","R01 MH107345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12035-021-02433-7","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T19:02:41Z","timestamp":1625079761000},"page":"4842-4855","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Higher CSF Ferritin Heavy-Chain (Fth1) and Transferrin Predict Better Neurocognitive Performance in People with HIV"],"prefix":"10.1007","volume":"58","author":[{"given":"Harpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott L.","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert K.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Patton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Hulgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6483-523X","authenticated-orcid":false,"given":"Asha R.","family":"Kallianpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"issue":"4","key":"2433_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","volume":"12","author":"D Saylor","year":"2016","unstructured":"Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, Mankowski JL, Brown A et al (2016) HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol 12(4):234\u2013248. https:\/\/doi.org\/10.1038\/nrneurol.2016.27","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2433_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s13365-018-0682-9","volume":"25","author":"A Alakkas","year":"2019","unstructured":"Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C et al (2019) White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neuro-Oncol 25(1):32\u201341. https:\/\/doi.org\/10.1007\/s13365-018-0682-9","journal-title":"J Neuro-Oncol"},{"key":"2433_CR3","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s11682-019-00153-0","volume":"14","author":"C Fennema-Notestine","year":"2019","unstructured":"Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR Jr, Anderson AM, Heaton RK et al (2019) Iron-regulatory genes are associated with neuroimaging measures in HIV infection. Brain Imaging Behav 14:2037\u20132049. https:\/\/doi.org\/10.1007\/s11682-019-00153-0","journal-title":"Brain Imaging Behav"},{"issue":"7","key":"2433_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/infdis\/jiv754","volume":"213","author":"AR Kallianpur","year":"2016","unstructured":"Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK et al (2016) Anemia and Red blood cell indices predict HIV-associated neurocognitive impairment in the highly active antiretroviral therapy era. J Infect Dis 213(7):1065\u20131073. https:\/\/doi.org\/10.1093\/infdis\/jiv754","journal-title":"J Infect Dis"},{"issue":"2","key":"2433_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1021\/acs.molpharmaceut.8b01014","volume":"16","author":"M Velichkovska","year":"2019","unstructured":"Velichkovska M, Surnar B, Nair M, Dhar S, Toborek M (2019) Targeted mitochondrial COQ10 delivery attenuates antiretroviral-drug-induced senescence of neural progenitor cells. Mol Pharm 16(2):724\u2013736. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b01014","journal-title":"Mol Pharm"},{"issue":"1","key":"2433_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13365-013-0227-1","volume":"20","author":"C Akay","year":"2014","unstructured":"Akay C, Cooper M, Odeleye A, Jensen BK, White MG, Vassoler F, Gannon PJ, Mankowski J et al (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. J Neuro-Oncol 20(1):39\u201353. https:\/\/doi.org\/10.1007\/s13365-013-0227-1","journal-title":"J Neuro-Oncol"},{"key":"2433_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12985-015-0298-0","volume":"12","author":"M Borsa","year":"2015","unstructured":"Borsa M, Ferreira PL, Petry A, Ferreira LG, Camargo MM, Bou-Habib DC, Pinto AR (2015) HIV infection and antiretroviral therapy lead to unfolded protein response activation. Virol J 12:77. https:\/\/doi.org\/10.1186\/s12985-015-0298-0","journal-title":"Virol J"},{"key":"2433_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11481-019-09893-8","volume":"16","author":"L Festa","year":"2019","unstructured":"Festa L, Roth LM, B KJ, Geiger JD, Jordan-Sciutto KL, Grinspan JB (2019) Protease inhibitors, saquinavir and darunavir, inhibit oligodendrocyte maturation: implications for lysosomal stress. J NeuroImmune Pharmacol 16:169\u2013180. https:\/\/doi.org\/10.1007\/s11481-019-09893-8","journal-title":"J NeuroImmune Pharmacol"},{"key":"2433_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.irn.2019.04.003","volume":"145","author":"JA Fields","year":"2019","unstructured":"Fields JA, Ellis RJ (2019) HIV in the cART era and the mitochondrial: immune interface in the CNS. Int Rev Neurobiol 145:29\u201365. https:\/\/doi.org\/10.1016\/bs.irn.2019.04.003","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"2433_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/QAI.0000000000001091","volume":"73","author":"LA Wendelken","year":"2016","unstructured":"Wendelken LA, Jahanshad N, Rosen HJ, Busovaca E, Allen I, Coppola G, Adams C, Rankin KP et al (2016) ApoE epsilon4 is associated with cognition, brain integrity, and atrophy in HIV over age 60. J Acquir Immune Defic Syndr 73(4):426\u2013432. https:\/\/doi.org\/10.1097\/QAI.0000000000001091","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2433_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13365-018-0660-2","volume":"24","author":"R Geffin","year":"2018","unstructured":"Geffin R, McCarthy M (2018) Aging and apolipoprotein E in HIV infection. J Neuro-Oncol 24(5):529\u2013548. https:\/\/doi.org\/10.1007\/s13365-018-0660-2","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"2433_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12987-017-0058-1","volume":"14","author":"SM Patton","year":"2017","unstructured":"Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre SL, Ellis RJ et al (2017) Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids Barriers CNS 14(1):11. https:\/\/doi.org\/10.1186\/s12987-017-0058-1","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"2433_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/jnc.14834","volume":"152","author":"B Chiou","year":"2020","unstructured":"Chiou B, Neely EB, McDevitt DS, Simpson IA, Connor JR (2020) Transferrin and H-ferritin involvement in brain iron acquisition during postnatal development: impact of sex and genotype. J Neurochem 152(3):381\u2013396. https:\/\/doi.org\/10.1111\/jnc.14834","journal-title":"J Neurochem"},{"key":"2433_CR14","doi-asserted-by":"publisher","unstructured":"Kuhn S, Gritti L, Crooks D, Dombrowski Y (2019) Oligodendrocytes in development, myelin generation and beyond. Cells 8(11). https:\/\/doi.org\/10.3390\/cells8111424","DOI":"10.3390\/cells8111424"},{"issue":"Suppl 1","key":"2433_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13425","volume":"139","author":"AA Belaidi","year":"2016","unstructured":"Belaidi AA, Bush AI (2016) Iron neurochemistry in Alzheimer\u2019s disease and Parkinson\u2019s disease: targets for therapeutics. J Neurochem 139(Suppl 1):179\u2013197. https:\/\/doi.org\/10.1111\/jnc.13425","journal-title":"J Neurochem"},{"issue":"7","key":"2433_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/glia.23313","volume":"66","author":"B Chiou","year":"2018","unstructured":"Chiou B, Lucassen E, Sather M, Kallianpur A, Connor J (2018) Semaphorin4A and H-ferritin utilize Tim-1 on human oligodendrocytes: a novel neuro-immune axis. Glia 66(7):1317\u20131330. https:\/\/doi.org\/10.1002\/glia.23313","journal-title":"Glia"},{"issue":"4","key":"2433_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s13365-013-0185-7","volume":"19","author":"C Fennema-Notestine","year":"2013","unstructured":"Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre SL, Notestine RJ, Taylor MJ, Theilmann RJ et al (2013) Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neuro-Oncol 19(4):393\u2013401. https:\/\/doi.org\/10.1007\/s13365-013-0185-7","journal-title":"J Neuro-Oncol"},{"issue":"3","key":"2433_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13365-011-0032-7","volume":"17","author":"TL Jernigan","year":"2011","unstructured":"Jernigan TL, Archibald SL, Fennema-Notestine C, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Wolfson T et al (2011) Clinical factors related to brain structure in HIV: the CHARTER study. J Neuro-Oncol 17(3):248\u2013257. https:\/\/doi.org\/10.1007\/s13365-011-0032-7","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"2433_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20150787","volume":"472","author":"P Arosio","year":"2015","unstructured":"Arosio P, Carmona F, Gozzelino R, Maccarinelli F, Poli M (2015) The importance of eukaryotic ferritins in iron handling and cytoprotection. Biochem J 472(1):1\u201315. https:\/\/doi.org\/10.1042\/BJ20150787","journal-title":"Biochem J"},{"issue":"9","key":"2433_CR20","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","volume":"116","author":"LA Cohen","year":"2010","unstructured":"Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, Sougrat R, Morgenstern A et al (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116(9):1574\u20131584. https:\/\/doi.org\/10.1182\/blood-2009-11-253815","journal-title":"Blood"},{"issue":"6","key":"2433_CR21","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/glia.21164","volume":"59","author":"B Todorich","year":"2011","unstructured":"Todorich B, Zhang X, Connor JR (2011) H-ferritin is the major source of iron for oligodendrocytes. Glia 59(6):927\u2013935. https:\/\/doi.org\/10.1002\/glia.21164","journal-title":"Glia"},{"key":"2433_CR22","doi-asserted-by":"publisher","unstructured":"Chiou B, Connor JR (2018) Emerging and dynamic biomedical uses of ferritin. Pharmaceuticals (Basel) 11(4). https:\/\/doi.org\/10.3390\/ph11040124","DOI":"10.3390\/ph11040124"},{"issue":"22","key":"2433_CR23","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.febslet.2015.08.001","volume":"589","author":"PG Franco","year":"2015","unstructured":"Franco PG, Pasquini LA, Perez MJ, Rosato-Siri MV, Silvestroff L, Pasquini JM (2015) Paving the way for adequate myelination: the contribution of galectin-3, transferrin and iron. FEBS Lett 589(22):3388\u20133395. https:\/\/doi.org\/10.1016\/j.febslet.2015.08.001","journal-title":"FEBS Lett"},{"issue":"3","key":"2433_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.bbagen.2011.10.016","volume":"1820","author":"DF Leitner","year":"2012","unstructured":"Leitner DF, Connor JR (2012) Functional roles of transferrin in the brain. Biochim Biophys Acta 1820(3):393\u2013402. https:\/\/doi.org\/10.1016\/j.bbagen.2011.10.016","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2433_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/glia.23891","volume":"69","author":"MV Rosato-Siri","year":"2021","unstructured":"Rosato-Siri MV, Marziali LN, Mattera V, Correale J, Pasquini JM (2021) Combination therapy of apo-transferrin and thyroid hormones enhances remyelination. Glia 69(1):151\u2013164. https:\/\/doi.org\/10.1002\/glia.23891","journal-title":"Glia"},{"issue":"8","key":"2433_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nri3863","volume":"15","author":"T Ganz","year":"2015","unstructured":"Ganz T, Nemeth E (2015) Iron homeostasis in host defence and inflammation. Nat Rev Immunol 15(8):500\u2013510. https:\/\/doi.org\/10.1038\/nri3863","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2433_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrn3453","volume":"14","author":"TA Rouault","year":"2013","unstructured":"Rouault TA (2013) Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 14(8):551\u2013564. https:\/\/doi.org\/10.1038\/nrn3453","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"2433_CR28","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1523\/JNEUROSCI.2434-19.2020","volume":"40","author":"B Larsen","year":"2020","unstructured":"Larsen B, Bourque J, Moore TM, Adebimpe A, Calkins ME, Elliott MA, Gur RC, Gur RE et al (2020) Longitudinal development of brain iron is linked to cognition in youth. J Neurosci 40(9):1810\u20131818. https:\/\/doi.org\/10.1523\/JNEUROSCI.2434-19.2020","journal-title":"J Neurosci"},{"issue":"5","key":"2433_CR29","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1007\/s12035-018-1329-9","volume":"56","author":"AR Kallianpur","year":"2019","unstructured":"Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC et al (2019) Cerebrospinal fluid ceruloplasmin, haptoglobin, and vascular endothelial growth factor are associated with neurocognitive impairment in adults with HIV infection. Mol Neurobiol 56(5):3808\u20133818. https:\/\/doi.org\/10.1007\/s12035-018-1329-9","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2433_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12974-017-0848-z","volume":"14","author":"SR Mehta","year":"2017","unstructured":"Mehta SR, Perez-Santiago J, Hulgan T, Day TR, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R et al (2017) Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation 14(1):72. https:\/\/doi.org\/10.1186\/s12974-017-0848-z","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2433_CR31","first-page":"181","volume":"73","author":"F Deisenhammer","year":"1997","unstructured":"Deisenhammer F, Miller RF, Brink NS, Harrison MJ, Thompson EJ (1997) Cerebrospinal fluid ferritin in HIV infected patients with acute neurological episodes. Genitourin Med 73(3):181\u2013183","journal-title":"Genitourin Med"},{"issue":"4","key":"2433_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/infdis\/168.4.1079","volume":"168","author":"O Perrella","year":"1993","unstructured":"Perrella O, Finelli L, Munno I, Perrella A, Soscia E, Carrieri PB (1993) Cerebrospinal fluid ferritin in human immunodeficiency virus infection: a marker of neurologic involvement? J Infect Dis 168(4):1079\u20131080","journal-title":"J Infect Dis"},{"issue":"3","key":"2433_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/cid\/ciu862","volume":"60","author":"RK Heaton","year":"2015","unstructured":"Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine MJ, Woods SP et al (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473\u2013480. https:\/\/doi.org\/10.1093\/cid\/ciu862","journal-title":"Clin Infect Dis"},{"issue":"23","key":"2433_CR34","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","volume":"75","author":"RK Heaton","year":"2010","unstructured":"Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL et al (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75(23):2087\u20132096. https:\/\/doi.org\/10.1212\/WNL.0b013e318200d727","journal-title":"Neurology"},{"issue":"6","key":"2433_CR35","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/13854046.2012.694479","volume":"26","author":"K Blackstone","year":"2012","unstructured":"Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC et al (2012) Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol 26(6):894\u2013908. https:\/\/doi.org\/10.1080\/13854046.2012.694479","journal-title":"Clin Neuropsychol"},{"issue":"48","key":"2433_CR36","doi-asserted-by":"publisher","first-page":"12729","DOI":"10.1021\/bi8016735","volume":"47","author":"CA Butts","year":"2008","unstructured":"Butts CA, Swift J, Kang SG, Di Costanzo L, Christianson DW, Saven JG, Dmochowski IJ (2008) Directing noble metal ion chemistry within a designed ferritin protein. Biochemistry 47(48):12729\u201312739. https:\/\/doi.org\/10.1021\/bi8016735","journal-title":"Biochemistry"},{"issue":"12","key":"2433_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188332","volume":"12","author":"AS Sacri","year":"2017","unstructured":"Sacri AS, Ferreira D, Khoshnood B, Gouya L, Barros H, Chalumeau M (2017) Stability of serum ferritin measured by immunoturbidimetric assay after storage at -80 degrees C for several years. PLoS One 12(12):e0188332. https:\/\/doi.org\/10.1371\/journal.pone.0188332","journal-title":"PLoS One"},{"issue":"11","key":"2433_CR38","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1111\/trf.15513","volume":"59","author":"BR Spencer","year":"2019","unstructured":"Spencer BR, Brodsky JP, Holley GC, Foster GA, Winton C, Stramer SL (2019) Expanded feasibility of ferritin testing: stability of ferritin stored as whole blood and validation of plastic tubes. Transfusion 59(11):3424\u20133430. https:\/\/doi.org\/10.1111\/trf.15513","journal-title":"Transfusion"},{"issue":"4","key":"2433_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/1354750X.2013.781223","volume":"18","author":"EH Jansen","year":"2013","unstructured":"Jansen EH, Beekhof PK, Schenk E (2013) Long-term stability of biomarkers of the iron status in human serum and plasma. Biomarkers 18(4):365\u2013368. https:\/\/doi.org\/10.3109\/1354750X.2013.781223","journal-title":"Biomarkers"},{"key":"2433_CR40","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3389\/fpsyg.2017.01841","volume":"8","author":"N Haverkamp","year":"2017","unstructured":"Haverkamp N, Beauducel A (2017) Violation of the Sphericity assumption and its effect on type-I error rates in repeated measures ANOVA and multi-level linear models (MLM). Front Psychol 8:1841. https:\/\/doi.org\/10.3389\/fpsyg.2017.01841","journal-title":"Front Psychol"},{"issue":"10","key":"2433_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1373\/clinchem.2019.306407","volume":"65","author":"T Ganz","year":"2019","unstructured":"Ganz T (2019) The discovery of the iron-regulatory hormone hepcidin. Clin Chem 65(10):1330\u20131331. https:\/\/doi.org\/10.1373\/clinchem.2019.306407","journal-title":"Clin Chem"},{"issue":"5","key":"2433_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s13365-015-0366-7","volume":"21","author":"DP Sheppard","year":"2015","unstructured":"Sheppard DP, Iudicello JE, Bondi MW, Doyle KL, Morgan EE, Massman PJ, Gilbert PE, Woods SP (2015) Elevated rates of mild cognitive impairment in HIV disease. J Neuro-Oncol 21(5):576\u2013584. https:\/\/doi.org\/10.1007\/s13365-015-0366-7","journal-title":"J Neuro-Oncol"},{"key":"2433_CR43","doi-asserted-by":"publisher","first-page":"581346","DOI":"10.3389\/fneur.2020.581346","volume":"11","author":"J Wei","year":"2020","unstructured":"Wei J, Hou J, Su B, Jiang T, Guo C, Wang W, Zhang Y, Chang B et al (2020) The prevalence of Frascati-Criteria-Based HIV-Associated Neurocognitive Disorder (HAND) in HIV-infected adults: a systematic review and meta-analysis. Front Neurol 11:581346. https:\/\/doi.org\/10.3389\/fneur.2020.581346","journal-title":"Front Neurol"},{"key":"2433_CR44","doi-asserted-by":"publisher","first-page":"146397","DOI":"10.1016\/j.brainres.2019.146397","volume":"1724","author":"BK Jensen","year":"2019","unstructured":"Jensen BK, Roth LM, Grinspan JB, Jordan-Sciutto KL (2019) White matter loss and oligodendrocyte dysfunction in HIV: a consequence of the infection, the antiretroviral therapy or both? Brain Res 1724:146397. https:\/\/doi.org\/10.1016\/j.brainres.2019.146397","journal-title":"Brain Res"},{"issue":"14","key":"2433_CR45","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/QAD.0000000000000766","volume":"29","author":"J Hoare","year":"2015","unstructured":"Hoare J, Fouche JP, Phillips N, Joska JA, Paul R, Donald KA, Thomas KG, Stein DJ (2015) White matter micro-structural changes in ART-naive and ART-treated children and adolescents infected with HIV in South Africa. AIDS 29(14):1793\u20131801. https:\/\/doi.org\/10.1097\/QAD.0000000000000766","journal-title":"AIDS"},{"issue":"1","key":"2433_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12883-018-1069-5","volume":"18","author":"RL Li","year":"2018","unstructured":"Li RL, Sun J, Tang ZC, Zhang JJ, Li HJ (2018) Axonal chronic injury in treatment-naive HIV+ adults with asymptomatic neurocognitive impairment and its relationship with clinical variables and cognitive status. BMC Neurol 18(1):66. https:\/\/doi.org\/10.1186\/s12883-018-1069-5","journal-title":"BMC Neurol"},{"key":"2433_CR47","doi-asserted-by":"publisher","unstructured":"Liu H, Xu E, Liu J, Xiong H (2016) Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders. Brain Sci 6(3). https:\/\/doi.org\/10.3390\/brainsci6030023","DOI":"10.3390\/brainsci6030023"},{"issue":"32","key":"2433_CR48","doi-asserted-by":"publisher","first-page":"11384","DOI":"10.1523\/JNEUROSCI.4740-14.2015","volume":"35","author":"S Zou","year":"2015","unstructured":"Zou S, Fuss B, Fitting S, Hahn YK, Hauser KF, Knapp PE (2015) Oligodendrocytes are targets of HIV-1 Tat: NMDA and AMPA receptor-mediated effects on survival and development. J Neurosci 35(32):11384\u201311398. https:\/\/doi.org\/10.1523\/JNEUROSCI.4740-14.2015","journal-title":"J Neurosci"},{"issue":"3","key":"2433_CR49","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/aid.2014.0169","volume":"31","author":"HC Chang","year":"2015","unstructured":"Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H (2015) Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retrovir 31(3):305\u2013312. https:\/\/doi.org\/10.1089\/aid.2014.0169","journal-title":"AIDS Res Hum Retrovir"},{"issue":"33","key":"2433_CR50","doi-asserted-by":"publisher","first-page":"12187","DOI":"10.1073\/pnas.1402351111","volume":"111","author":"AE Armitage","year":"2014","unstructured":"Armitage AE, Stacey AR, Giannoulatou E, Marshall E, Sturges P, Chatha K, Smith NM, Huang X et al (2014) Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc Natl Acad Sci U S A 111(33):12187\u201312192. https:\/\/doi.org\/10.1073\/pnas.1402351111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"2433_CR51","doi-asserted-by":"publisher","first-page":"11017","DOI":"10.1073\/pnas.0504823102","volume":"102","author":"H Drakesmith","year":"2005","unstructured":"Drakesmith H, Chen N, Ledermann H, Screaton G, Townsend A, Xu XN (2005) HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A 102(31):11017\u201311022. https:\/\/doi.org\/10.1073\/pnas.0504823102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2433_CR52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/QCO.0000000000000328","volume":"30","author":"DB Clifford","year":"2017","unstructured":"Clifford DB (2017) HIV-associated neurocognitive disorder. Curr Opin Infect Dis 30(1):117\u2013122. https:\/\/doi.org\/10.1097\/QCO.0000000000000328","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"2433_CR53","first-page":"26","volume":"27","author":"BM Ances","year":"2019","unstructured":"Ances BM, Letendre SL (2019) CROI 2019: neurologic complications of HIV disease. Top Antivir Med 27(1):26\u201333","journal-title":"Top Antivir Med"},{"issue":"5","key":"2433_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/glia.20784","volume":"57","author":"B Todorich","year":"2009","unstructured":"Todorich B, Pasquini JM, Garcia CI, Paez PM, Connor JR (2009) Oligodendrocytes and myelination: the role of iron. Glia 57(5):467\u2013478. https:\/\/doi.org\/10.1002\/glia.20784","journal-title":"Glia"},{"key":"2433_CR55","doi-asserted-by":"publisher","unstructured":"Alejandro D. Roth MTN (2016) Oligodendrocytes: functioning in a delicate balance between high metabolic requirements and oxidative damage. In: Glial Cells in Health and Disease of the CNS, vol 949. Springer, Cham, pp 167-181. doi:https:\/\/doi.org\/10.1007\/978-3-319-40764-7_8","DOI":"10.1007\/978-3-319-40764-7_8"},{"issue":"20","key":"2433_CR56","doi-asserted-by":"publisher","first-page":"7853","DOI":"10.1074\/jbc.RA118.001949","volume":"293","author":"RC McCarthy","year":"2018","unstructured":"McCarthy RC, Sosa JC, Gardeck AM, Baez AS, Lee CH, Wessling-Resnick M (2018) Inflammation-induced iron transport and metabolism by brain microglia. J Biol Chem 293(20):7853\u20137863. https:\/\/doi.org\/10.1074\/jbc.RA118.001949","journal-title":"J Biol Chem"},{"issue":"8","key":"2433_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023800","volume":"6","author":"J Han","year":"2011","unstructured":"Han J, Seaman WE, Di X, Wang W, Willingham M, Torti FM, Torti SV (2011) Iron uptake mediated by binding of H-ferritin to the TIM-2 receptor in mouse cells. PLoS One 6(8):e23800. https:\/\/doi.org\/10.1371\/journal.pone.0023800","journal-title":"PLoS One"},{"issue":"8","key":"2433_CR58","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/glia.20416","volume":"54","author":"X Zhang","year":"2006","unstructured":"Zhang X, Surguladze N, Slagle-Webb B, Cozzi A, Connor JR (2006) Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 54(8):795\u2013804. https:\/\/doi.org\/10.1002\/glia.20416","journal-title":"Glia"},{"issue":"1","key":"2433_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/1097-4547(20000701)61:1<52::AID-JNR6>3.0.CO;2-T","volume":"61","author":"SW Hulet","year":"2000","unstructured":"Hulet SW, Heyliger SO, Powers S, Connor JR (2000) Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res 61(1):52\u201360. https:\/\/doi.org\/10.1002\/1097-4547(20000701)61:1<52::AID-JNR6>3.0.CO;2-T","journal-title":"J Neurosci Res"},{"issue":"8","key":"2433_CR60","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1073\/pnas.0913192107","volume":"107","author":"L Li","year":"2010","unstructured":"Li L, Fang CJ, Ryan JC, Niemi EC, Lebron JA, Bjorkman PJ, Arase H, Torti FM et al (2010) Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci U S A 107(8):3505\u20133510. https:\/\/doi.org\/10.1073\/pnas.0913192107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"2433_CR61","doi-asserted-by":"publisher","first-page":"7609","DOI":"10.1523\/JNEUROSCI.1281-20.2020","volume":"40","author":"R Wan","year":"2020","unstructured":"Wan R, Cheli VT, Santiago-Gonzalez DA, Rosenblum SL, Wan Q, Paez PM (2020) Impaired postnatal myelination in a conditional knockout mouse for the ferritin heavy chain in oligodendroglial cells. J Neurosci 40(40):7609\u20137624. https:\/\/doi.org\/10.1523\/JNEUROSCI.1281-20.2020","journal-title":"J Neurosci"},{"issue":"12","key":"2433_CR62","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.bbagen.2015.09.018","volume":"1850","author":"HT Cheng","year":"2015","unstructured":"Cheng HT, Yen CJ, Chang CC, Huang KT, Chen KH, Zhang RY, Lee PY, Miaw SC et al (2015) Ferritin heavy chain mediates the protective effect of heme oxygenase-1 against oxidative stress. Biochim Biophys Acta 1850(12):2506\u20132517. https:\/\/doi.org\/10.1016\/j.bbagen.2015.09.018","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"2433_CR63","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2020.05.019","volume":"32","author":"C Mukherjee","year":"2020","unstructured":"Mukherjee C, Kling T, Russo B, Miebach K, Kess E, Schifferer M, Pedro LD, Weikert U et al (2020) Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metab 32(2):259\u2013272 e210. https:\/\/doi.org\/10.1016\/j.cmet.2020.05.019","journal-title":"Cell Metab"},{"issue":"1","key":"2433_CR64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-019-1420-9","volume":"16","author":"B Chiou","year":"2019","unstructured":"Chiou B, Neely E, Kallianpur A, Connor JR (2019) Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo. J Neuroinflammation 16(1):28. https:\/\/doi.org\/10.1186\/s12974-019-1420-9","journal-title":"J Neuroinflammation"},{"issue":"3","key":"2433_CR65","doi-asserted-by":"publisher","first-page":"175909141558750","DOI":"10.1177\/1759091415587502","volume":"7","author":"DF Leitner","year":"2015","unstructured":"Leitner DF, Todorich B, Zhang X, Connor JR (2015) Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis. ASN Neuro 7(3):175909141558750. https:\/\/doi.org\/10.1177\/1759091415587502","journal-title":"ASN Neuro"},{"issue":"1","key":"2433_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jnr.10463","volume":"71","author":"K Thompson","year":"2003","unstructured":"Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J et al (2003) Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 71(1):46\u201363. https:\/\/doi.org\/10.1002\/jnr.10463","journal-title":"J Neurosci Res"},{"issue":"6","key":"2433_CR67","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/(sici)1098-2825(1999)13:6<273::aid-jcla4>3.0.co;2-x","volume":"13","author":"RF Ritchie","year":"1999","unstructured":"Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY (1999) Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 13(6):273\u2013279. https:\/\/doi.org\/10.1002\/(sici)1098-2825(1999)13:6<273::aid-jcla4>3.0.co;2-x","journal-title":"J Clin Lab Anal"},{"key":"2433_CR68","doi-asserted-by":"publisher","unstructured":"Daruich A, Le Rouzic Q, Jonet L, Naud MC, Kowalczuk L, Pournaras JA, Boatright JH, Thomas A, Turck N, Moulin A, Behar-Cohen F, Picard E (2019) Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection. Sci Adv 5 (1):eaau9940. doi:https:\/\/doi.org\/10.1126\/sciadv.aau9940","DOI":"10.1126\/sciadv.aau9940"},{"issue":"4","key":"2433_CR69","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11011-009-9169-y","volume":"24","author":"TA Rouault","year":"2009","unstructured":"Rouault TA, Zhang DL, Jeong SY (2009) Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins. Metab Brain Dis 24(4):673\u2013684. https:\/\/doi.org\/10.1007\/s11011-009-9169-y","journal-title":"Metab Brain Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02433-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T06:33:30Z","timestamp":1633674810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02433-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02433-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2021,6,30]]},"assertion":[{"value":"12 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CHARTER is a multi-center study which has received continuous approval by the institutional review boards (IRBs) of all participating institutions\/sites. IRB approval numbers can be provided upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All CHARTER study participants provided written informed consent for the parent study that provided the de-identified CSF samples and data for this analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors provided consent for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Authors Kaur, Bush, Letendre, Franklin, Ellis, Hulgan, Heaton, Samuels, and Kallianpur have no potential conflicts of interest to disclose. Author S. Patton is a paid consultant for SideroBiosciences, Inc., and J.R. Connor, a longstanding collaborator, is co-founder and Chairman of the Board of SideroBiosciences, which has a product in clinical trials for treating iron deficiency.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}